Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Valacyclovir × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4 Thoracic 3 Genitourinary 3 Other hematologic neoplasm 2 Lymphoid 2 Breast 2 Tumor-Agnostic 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1192 Fluorouracil 1107 Capecitabine 917 Gemcitabine 878 Leucovorin 783 Irinotecan 690 Bevacizumab 688 Cisplatin 563 Radiotherapy 483 Cetuximab 402 pembrolizumab 364 Paclitaxel 337 Drug Therapy 303 Nivolumab 282 130-nm albumin-bound paclitaxel 261 Docetaxel 253 Sorafenib 251 S 1 (combination) 236 Folfox protocol 225 Surgical Procedures, Operative 218 Albumin-Bound Paclitaxel 208 lenvatinib 184 durvalumab 179 apatinib 176 tislelizumab 175 sintilimab 168 Radiosurgery 167 regorafenib 166 Neoadjuvant Therapy 163 Magnetic Resonance Spectroscopy 160

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡